Emerson Electric Co.

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, ETN has a market cap of 137.8B. Regarding current trading prices, EMR is priced at $132.24, while ETN trades at $355.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas ETN's P/E ratio is 33.97. In terms of profitability, EMR's ROE is +0.12%, compared to ETN's ROE of +0.22%. Regarding short-term risk, EMR is less volatile compared to ETN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check ETN's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, PH has a market cap of 112.3B. Regarding current trading prices, EMR is priced at $132.24, while PH trades at $889.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas PH's P/E ratio is 32.52. In terms of profitability, EMR's ROE is +0.12%, compared to PH's ROE of +0.26%. Regarding short-term risk, EMR is less volatile compared to PH. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PH's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, HWM has a market cap of 95.3B. Regarding current trading prices, EMR is priced at $132.24, while HWM trades at $236.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas HWM's P/E ratio is 64.53. In terms of profitability, EMR's ROE is +0.12%, compared to HWM's ROE of +0.30%. Regarding short-term risk, EMR is less volatile compared to HWM. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HWM's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, ITW has a market cap of 77B. Regarding current trading prices, EMR is priced at $132.24, while ITW trades at $266.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas ITW's P/E ratio is 25.48. In terms of profitability, EMR's ROE is +0.12%, compared to ITW's ROE of +0.95%. Regarding short-term risk, EMR is more volatile compared to ITW. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check ITW's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CMI has a market cap of 74B. Regarding current trading prices, EMR is priced at $132.24, while CMI trades at $535.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CMI's P/E ratio is 26.11. In terms of profitability, EMR's ROE is +0.12%, compared to CMI's ROE of +0.24%. Regarding short-term risk, EMR is less volatile compared to CMI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CMI's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, AME has a market cap of 49.4B. Regarding current trading prices, EMR is priced at $132.24, while AME trades at $214.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas AME's P/E ratio is 33.56. In terms of profitability, EMR's ROE is +0.12%, compared to AME's ROE of +0.14%. Regarding short-term risk, EMR is more volatile compared to AME. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check AME's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, ROK has a market cap of 40.6B. Regarding current trading prices, EMR is priced at $132.24, while ROK trades at $360.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas ROK's P/E ratio is 41.35. In terms of profitability, EMR's ROE is +0.12%, compared to ROK's ROE of +0.28%. Regarding short-term risk, EMR is less volatile compared to ROK. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check ROK's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, HWM-P has a market cap of 40.3B. Regarding current trading prices, EMR is priced at $132.24, while HWM-P trades at $100.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas HWM-P's P/E ratio is 140.74. In terms of profitability, EMR's ROE is +0.12%, compared to HWM-P's ROE of +0.30%. Regarding short-term risk, EMR is more volatile compared to HWM-P. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check HWM-P's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, ROP has a market cap of 37.8B. Regarding current trading prices, EMR is priced at $132.24, while ROP trades at $351.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas ROP's P/E ratio is 24.72. In terms of profitability, EMR's ROE is +0.12%, compared to ROP's ROE of +0.08%. Regarding short-term risk, EMR is more volatile compared to ROP. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check ROP's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, IR has a market cap of 32.4B. Regarding current trading prices, EMR is priced at $132.24, while IR trades at $82.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas IR's P/E ratio is 57.42. In terms of profitability, EMR's ROE is +0.12%, compared to IR's ROE of +0.06%. Regarding short-term risk, EMR is less volatile compared to IR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check IR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, OTIS has a market cap of 32.4B. Regarding current trading prices, EMR is priced at $132.24, while OTIS trades at $83.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas OTIS's P/E ratio is 23.77. In terms of profitability, EMR's ROE is +0.12%, compared to OTIS's ROE of -0.26%. Regarding short-term risk, EMR is more volatile compared to OTIS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check OTIS's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, SYM has a market cap of 30.5B. Regarding current trading prices, EMR is priced at $132.24, while SYM trades at $49.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas SYM's P/E ratio is -449.36. In terms of profitability, EMR's ROE is +0.12%, compared to SYM's ROE of -0.03%. Regarding short-term risk, EMR is less volatile compared to SYM. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SYM's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, XYL has a market cap of 29.2B. Regarding current trading prices, EMR is priced at $132.24, while XYL trades at $119.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas XYL's P/E ratio is 30.74. In terms of profitability, EMR's ROE is +0.12%, compared to XYL's ROE of +0.09%. Regarding short-term risk, EMR is more volatile compared to XYL. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check XYL's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, DOV has a market cap of 28B. Regarding current trading prices, EMR is priced at $132.24, while DOV trades at $203.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas DOV's P/E ratio is 25.58. In terms of profitability, EMR's ROE is +0.12%, compared to DOV's ROE of +0.15%. Regarding short-term risk, EMR is more volatile compared to DOV. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check DOV's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, ITT has a market cap of 16.2B. Regarding current trading prices, EMR is priced at $132.24, while ITT trades at $187.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas ITT's P/E ratio is 30.68. In terms of profitability, EMR's ROE is +0.12%, compared to ITT's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to ITT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check ITT's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, NDSN has a market cap of 14.9B. Regarding current trading prices, EMR is priced at $132.24, while NDSN trades at $267.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas NDSN's P/E ratio is 28.93. In terms of profitability, EMR's ROE is +0.12%, compared to NDSN's ROE of +0.17%. Regarding short-term risk, EMR is less volatile compared to NDSN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NDSN's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, GGG has a market cap of 14.5B. Regarding current trading prices, EMR is priced at $132.24, while GGG trades at $87.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas GGG's P/E ratio is 28.45. In terms of profitability, EMR's ROE is +0.12%, compared to GGG's ROE of +0.20%. Regarding short-term risk, EMR is less volatile compared to GGG. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GGG's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, PNR has a market cap of 14.4B. Regarding current trading prices, EMR is priced at $132.24, while PNR trades at $88.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas PNR's P/E ratio is 22.46. In terms of profitability, EMR's ROE is +0.12%, compared to PNR's ROE of +0.17%. Regarding short-term risk, EMR is more volatile compared to PNR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check PNR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, IEX has a market cap of 14.1B. Regarding current trading prices, EMR is priced at $132.24, while IEX trades at $188.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas IEX's P/E ratio is 29.31. In terms of profitability, EMR's ROE is +0.12%, compared to IEX's ROE of +0.12%. Regarding short-term risk, EMR is more volatile compared to IEX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check IEX's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, RRX has a market cap of 12.4B. Regarding current trading prices, EMR is priced at $132.24, while RRX trades at $186.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas RRX's P/E ratio is 44.23. In terms of profitability, EMR's ROE is +0.12%, compared to RRX's ROE of +0.04%. Regarding short-term risk, EMR is less volatile compared to RRX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check RRX's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, GNRC has a market cap of 11.8B. Regarding current trading prices, EMR is priced at $132.24, while GNRC trades at $200.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas GNRC's P/E ratio is 74.27. In terms of profitability, EMR's ROE is +0.12%, compared to GNRC's ROE of +0.06%. Regarding short-term risk, EMR is less volatile compared to GNRC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GNRC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, SPXC has a market cap of 10B. Regarding current trading prices, EMR is priced at $132.24, while SPXC trades at $199.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas SPXC's P/E ratio is 39.36. In terms of profitability, EMR's ROE is +0.12%, compared to SPXC's ROE of +0.13%. Regarding short-term risk, EMR is less volatile compared to SPXC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SPXC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, DCI has a market cap of 9.9B. Regarding current trading prices, EMR is priced at $132.24, while DCI trades at $85.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas DCI's P/E ratio is 26.81. In terms of profitability, EMR's ROE is +0.12%, compared to DCI's ROE of +0.25%. Regarding short-term risk, EMR is less volatile compared to DCI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check DCI's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, WTS has a market cap of 9.9B. Regarding current trading prices, EMR is priced at $132.24, while WTS trades at $297.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas WTS's P/E ratio is 29.27. In terms of profitability, EMR's ROE is +0.12%, compared to WTS's ROE of +0.18%. Regarding short-term risk, EMR is less volatile compared to WTS. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check WTS's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, GTLS has a market cap of 9.9B. Regarding current trading prices, EMR is priced at $132.24, while GTLS trades at $206.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas GTLS's P/E ratio is 626.61. In terms of profitability, EMR's ROE is +0.12%, compared to GTLS's ROE of +0.01%. Regarding short-term risk, EMR is more volatile compared to GTLS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GTLS's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CR has a market cap of 9.9B. Regarding current trading prices, EMR is priced at $132.24, while CR trades at $171.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CR's P/E ratio is 30.18. In terms of profitability, EMR's ROE is +0.12%, compared to CR's ROE of +0.19%. Regarding short-term risk, EMR is less volatile compared to CR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, FLS has a market cap of 9.5B. Regarding current trading prices, EMR is priced at $132.24, while FLS trades at $74.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas FLS's P/E ratio is 28.13. In terms of profitability, EMR's ROE is +0.12%, compared to FLS's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to FLS. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check FLS's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, AOS has a market cap of 9.4B. Regarding current trading prices, EMR is priced at $132.24, while AOS trades at $66.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas AOS's P/E ratio is 17.36. In terms of profitability, EMR's ROE is +0.12%, compared to AOS's ROE of +0.30%. Regarding short-term risk, EMR is more volatile compared to AOS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check AOS's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, MIDD has a market cap of 7.2B. Regarding current trading prices, EMR is priced at $132.24, while MIDD trades at $143.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas MIDD's P/E ratio is 20.15. In terms of profitability, EMR's ROE is +0.12%, compared to MIDD's ROE of -0.09%. Regarding short-term risk, EMR is less volatile compared to MIDD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MIDD's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, JBTM has a market cap of 6.7B. Regarding current trading prices, EMR is priced at $132.24, while JBTM trades at $129.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas JBTM's P/E ratio is -133.60. In terms of profitability, EMR's ROE is +0.12%, compared to JBTM's ROE of -0.01%. Regarding short-term risk, EMR is less volatile compared to JBTM. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check JBTM's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, AEBIV has a market cap of 6.5B. Regarding current trading prices, EMR is priced at $132.24, while AEBIV trades at $83.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas AEBIV's P/E ratio is 213.49. In terms of profitability, EMR's ROE is +0.12%, compared to AEBIV's ROE of -0.00%. Regarding short-term risk, EMR is more volatile compared to AEBIV. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check AEBIV's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, PSN has a market cap of 5.9B. Regarding current trading prices, EMR is priced at $132.24, while PSN trades at $54.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas PSN's P/E ratio is 24.98. In terms of profitability, EMR's ROE is +0.12%, compared to PSN's ROE of +0.09%. Regarding short-term risk, EMR is less volatile compared to PSN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PSN's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, GTES has a market cap of 5.9B. Regarding current trading prices, EMR is priced at $132.24, while GTES trades at $22.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas GTES's P/E ratio is 23.94. In terms of profitability, EMR's ROE is +0.12%, compared to GTES's ROE of +0.08%. Regarding short-term risk, EMR is less volatile compared to GTES. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GTES's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, NPO has a market cap of 5.1B. Regarding current trading prices, EMR is priced at $132.24, while NPO trades at $240.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas NPO's P/E ratio is 126.09. In terms of profitability, EMR's ROE is +0.12%, compared to NPO's ROE of +0.03%. Regarding short-term risk, EMR is less volatile compared to NPO. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NPO's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CSWI has a market cap of 4.9B. Regarding current trading prices, EMR is priced at $132.24, while CSWI trades at $305.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CSWI's P/E ratio is 36.36. In terms of profitability, EMR's ROE is +0.12%, compared to CSWI's ROE of +0.12%. Regarding short-term risk, EMR is more volatile compared to CSWI. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CSWI's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, MIR has a market cap of 4.6B. Regarding current trading prices, EMR is priced at $132.24, while MIR trades at $18.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas MIR's P/E ratio is 169.95. In terms of profitability, EMR's ROE is +0.12%, compared to MIR's ROE of +0.02%. Regarding short-term risk, EMR is less volatile compared to MIR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MIR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, MWA has a market cap of 4.3B. Regarding current trading prices, EMR is priced at $132.24, while MWA trades at $27.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas MWA's P/E ratio is 21.83. In terms of profitability, EMR's ROE is +0.12%, compared to MWA's ROE of +0.21%. Regarding short-term risk, EMR is less volatile compared to MWA. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MWA's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CSW has a market cap of 4.3B. Regarding current trading prices, EMR is priced at $132.24, while CSW trades at $256.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CSW's P/E ratio is 33.98. In terms of profitability, EMR's ROE is +0.12%, compared to CSW's ROE of +0.12%. Regarding short-term risk, EMR is less volatile compared to CSW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CSW's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, AIMC has a market cap of 4.1B. Regarding current trading prices, EMR is priced at $132.24, while AIMC trades at $61.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas AIMC's P/E ratio is 31.95. In terms of profitability, EMR's ROE is +0.12%, compared to AIMC's ROE of +0.06%. Regarding short-term risk, EMR is more volatile compared to AIMC. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check AIMC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, FELE has a market cap of 4B. Regarding current trading prices, EMR is priced at $132.24, while FELE trades at $90.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas FELE's P/E ratio is 28.23. In terms of profitability, EMR's ROE is +0.12%, compared to FELE's ROE of +0.11%. Regarding short-term risk, EMR is less volatile compared to FELE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check FELE's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, JBT has a market cap of 4B. Regarding current trading prices, EMR is priced at $132.24, while JBT trades at $125.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas JBT's P/E ratio is 28.04. In terms of profitability, EMR's ROE is +0.12%, compared to JBT's ROE of -0.01%. Regarding short-term risk, EMR is less volatile compared to JBT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check JBT's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, KAI has a market cap of 3.6B. Regarding current trading prices, EMR is priced at $132.24, while KAI trades at $303.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas KAI's P/E ratio is 35.17. In terms of profitability, EMR's ROE is +0.12%, compared to KAI's ROE of +0.11%. Regarding short-term risk, EMR is less volatile compared to KAI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check KAI's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, GTLS-PB has a market cap of 3.2B. Regarding current trading prices, EMR is priced at $132.24, while GTLS-PB trades at $72.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas GTLS-PB's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to GTLS-PB's ROE of +0.01%. Regarding short-term risk, EMR is more volatile compared to GTLS-PB. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GTLS-PB's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, SXI has a market cap of 3.1B. Regarding current trading prices, EMR is priced at $132.24, while SXI trades at $253.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas SXI's P/E ratio is 56.69. In terms of profitability, EMR's ROE is +0.12%, compared to SXI's ROE of +0.08%. Regarding short-term risk, EMR is less volatile compared to SXI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SXI's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, ATS has a market cap of 2.7B. Regarding current trading prices, EMR is priced at $132.24, while ATS trades at $27.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas ATS's P/E ratio is 196.86. In terms of profitability, EMR's ROE is +0.12%, compared to ATS's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to ATS. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check ATS's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CXT has a market cap of 2.4B. Regarding current trading prices, EMR is priced at $132.24, while CXT trades at $42.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CXT's P/E ratio is 16.92. In terms of profitability, EMR's ROE is +0.12%, compared to CXT's ROE of +0.12%. Regarding short-term risk, EMR is less volatile compared to CXT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CXT's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, HI has a market cap of 2.3B. Regarding current trading prices, EMR is priced at $132.24, while HI trades at $31.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas HI's P/E ratio is 65.27. In terms of profitability, EMR's ROE is +0.12%, compared to HI's ROE of +0.03%. Regarding short-term risk, EMR is more volatile compared to HI. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check HI's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, HLIO has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $132.24, while HLIO trades at $64.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas HLIO's P/E ratio is 44.22. In terms of profitability, EMR's ROE is +0.12%, compared to HLIO's ROE of +0.05%. Regarding short-term risk, EMR is less volatile compared to HLIO. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HLIO's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CFX has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $132.24, while CFX trades at $39.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CFX's P/E ratio is 28.55. In terms of profitability, EMR's ROE is +0.12%, compared to CFX's ROE of -0.54%. Regarding short-term risk, EMR is less volatile compared to CFX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CFX's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, SHPW has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $132.24, while SHPW trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas SHPW's P/E ratio is -0.05. In terms of profitability, EMR's ROE is +0.12%, compared to SHPW's ROE of -0.93%. Regarding short-term risk, EMR is more volatile compared to SHPW. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check SHPW's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, BW-PA has a market cap of 2B. Regarding current trading prices, EMR is priced at $132.24, while BW-PA trades at $19.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas BW-PA's P/E ratio is 66.57. In terms of profitability, EMR's ROE is +0.12%, compared to BW-PA's ROE of +0.15%. Regarding short-term risk, EMR is less volatile compared to BW-PA. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BW-PA's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, EPAC has a market cap of 1.9B. Regarding current trading prices, EMR is priced at $132.24, while EPAC trades at $35.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas EPAC's P/E ratio is 21.61. In terms of profitability, EMR's ROE is +0.12%, compared to EPAC's ROE of +0.21%. Regarding short-term risk, EMR is less volatile compared to EPAC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check EPAC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, XMTR has a market cap of 1.9B. Regarding current trading prices, EMR is priced at $132.24, while XMTR trades at $36.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas XMTR's P/E ratio is -30.26. In terms of profitability, EMR's ROE is +0.12%, compared to XMTR's ROE of -0.22%. Regarding short-term risk, EMR is less volatile compared to XMTR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check XMTR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CYD has a market cap of 1.6B. Regarding current trading prices, EMR is priced at $132.24, while CYD trades at $41.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CYD's P/E ratio is 19.97. In terms of profitability, EMR's ROE is +0.12%, compared to CYD's ROE of +0.05%. Regarding short-term risk, EMR is less volatile compared to CYD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CYD's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, THR has a market cap of 1.5B. Regarding current trading prices, EMR is priced at $132.24, while THR trades at $46.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas THR's P/E ratio is 26.34. In terms of profitability, EMR's ROE is +0.12%, compared to THR's ROE of +0.11%. Regarding short-term risk, EMR is less volatile compared to THR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check THR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, GRC has a market cap of 1.5B. Regarding current trading prices, EMR is priced at $132.24, while GRC trades at $57.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas GRC's P/E ratio is 28.58. In terms of profitability, EMR's ROE is +0.12%, compared to GRC's ROE of +0.13%. Regarding short-term risk, EMR is less volatile compared to GRC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GRC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, AMSC has a market cap of 1.5B. Regarding current trading prices, EMR is priced at $132.24, while AMSC trades at $31.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas AMSC's P/E ratio is 10.20. In terms of profitability, EMR's ROE is +0.12%, compared to AMSC's ROE of +0.37%. Regarding short-term risk, EMR is less volatile compared to AMSC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check AMSC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, ENOV has a market cap of 1.3B. Regarding current trading prices, EMR is priced at $132.24, while ENOV trades at $22.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas ENOV's P/E ratio is -1.11. In terms of profitability, EMR's ROE is +0.12%, compared to ENOV's ROE of -0.54%. Regarding short-term risk, EMR is less volatile compared to ENOV. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check ENOV's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, PSIX has a market cap of 1.3B. Regarding current trading prices, EMR is priced at $132.24, while PSIX trades at $56.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas PSIX's P/E ratio is 11.49. In terms of profitability, EMR's ROE is +0.12%, compared to PSIX's ROE of +0.81%. Regarding short-term risk, EMR is less volatile compared to PSIX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PSIX's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, BW has a market cap of 1.2B. Regarding current trading prices, EMR is priced at $132.24, while BW trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas BW's P/E ratio is -23.34. In terms of profitability, EMR's ROE is +0.12%, compared to BW's ROE of +0.15%. Regarding short-term risk, EMR is less volatile compared to BW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BW's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, TNC has a market cap of 1.2B. Regarding current trading prices, EMR is priced at $132.24, while TNC trades at $63.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas TNC's P/E ratio is 27.01. In terms of profitability, EMR's ROE is +0.12%, compared to TNC's ROE of +0.07%. Regarding short-term risk, EMR is less volatile compared to TNC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check TNC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CIR has a market cap of 1.1B. Regarding current trading prices, EMR is priced at $132.24, while CIR trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CIR's P/E ratio is 38.89. In terms of profitability, EMR's ROE is +0.12%, compared to CIR's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to CIR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CIR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, NNE has a market cap of 948.9M. Regarding current trading prices, EMR is priced at $132.24, while NNE trades at $22.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas NNE's P/E ratio is -20.75. In terms of profitability, EMR's ROE is +0.12%, compared to NNE's ROE of -0.15%. Regarding short-term risk, EMR is less volatile compared to NNE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NNE's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, GHM has a market cap of 886.2M. Regarding current trading prices, EMR is priced at $132.24, while GHM trades at $80.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas GHM's P/E ratio is 59.28. In terms of profitability, EMR's ROE is +0.12%, compared to GHM's ROE of +0.12%. Regarding short-term risk, EMR is less volatile compared to GHM. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GHM's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, BLDP has a market cap of 718.8M. Regarding current trading prices, EMR is priced at $132.24, while BLDP trades at $2.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas BLDP's P/E ratio is -5.97. In terms of profitability, EMR's ROE is +0.12%, compared to BLDP's ROE of -0.14%. Regarding short-term risk, EMR is less volatile compared to BLDP. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BLDP's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, KRNT has a market cap of 631.7M. Regarding current trading prices, EMR is priced at $132.24, while KRNT trades at $13.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas KRNT's P/E ratio is -45.80. In terms of profitability, EMR's ROE is +0.12%, compared to KRNT's ROE of -0.02%. Regarding short-term risk, EMR is less volatile compared to KRNT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check KRNT's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, SERV has a market cap of 562M. Regarding current trading prices, EMR is priced at $132.24, while SERV trades at $9.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas SERV's P/E ratio is -6.33. In terms of profitability, EMR's ROE is +0.12%, compared to SERV's ROE of -0.39%. Regarding short-term risk, EMR is less volatile compared to SERV. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SERV's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, RR has a market cap of 424.3M. Regarding current trading prices, EMR is priced at $132.24, while RR trades at $2.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas RR's P/E ratio is -17.77. In terms of profitability, EMR's ROE is +0.12%, compared to RR's ROE of -0.11%. Regarding short-term risk, EMR is less volatile compared to RR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check RR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, PKOH has a market cap of 351.8M. Regarding current trading prices, EMR is priced at $132.24, while PKOH trades at $24.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas PKOH's P/E ratio is 11.91. In terms of profitability, EMR's ROE is +0.12%, compared to PKOH's ROE of +0.06%. Regarding short-term risk, EMR is less volatile compared to PKOH. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PKOH's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, BGRY has a market cap of 340.7M. Regarding current trading prices, EMR is priced at $132.24, while BGRY trades at $1.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas BGRY's P/E ratio is -2.86. In terms of profitability, EMR's ROE is +0.12%, compared to BGRY's ROE of -0.96%. Regarding short-term risk, EMR is more volatile compared to BGRY. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check BGRY's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, LXFR has a market cap of 309.7M. Regarding current trading prices, EMR is priced at $132.24, while LXFR trades at $11.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas LXFR's P/E ratio is 24.15. In terms of profitability, EMR's ROE is +0.12%, compared to LXFR's ROE of +0.14%. Regarding short-term risk, EMR is less volatile compared to LXFR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check LXFR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, OFLX has a market cap of 286.1M. Regarding current trading prices, EMR is priced at $132.24, while OFLX trades at $28.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas OFLX's P/E ratio is 17.83. In terms of profitability, EMR's ROE is +0.12%, compared to OFLX's ROE of +0.00%. Regarding short-term risk, EMR is less volatile compared to OFLX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check OFLX's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, SHMD has a market cap of 271.7M. Regarding current trading prices, EMR is priced at $132.24, while SHMD trades at $6.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas SHMD's P/E ratio is -5.95. In terms of profitability, EMR's ROE is +0.12%, compared to SHMD's ROE of +0.38%. Regarding short-term risk, EMR is less volatile compared to SHMD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SHMD's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, TAYD has a market cap of 234.7M. Regarding current trading prices, EMR is priced at $132.24, while TAYD trades at $74.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas TAYD's P/E ratio is 24.73. In terms of profitability, EMR's ROE is +0.12%, compared to TAYD's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to TAYD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check TAYD's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, TWIN has a market cap of 213.7M. Regarding current trading prices, EMR is priced at $132.24, while TWIN trades at $14.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas TWIN's P/E ratio is 9.75. In terms of profitability, EMR's ROE is +0.12%, compared to TWIN's ROE of +0.13%. Regarding short-term risk, EMR is less volatile compared to TWIN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check TWIN's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, HUHU has a market cap of 151.1M. Regarding current trading prices, EMR is priced at $132.24, while HUHU trades at $6.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas HUHU's P/E ratio is -12.06. In terms of profitability, EMR's ROE is +0.12%, compared to HUHU's ROE of -1.71%. Regarding short-term risk, EMR is less volatile compared to HUHU. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HUHU's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, NPWR has a market cap of 143.5M. Regarding current trading prices, EMR is priced at $132.24, while NPWR trades at $1.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas NPWR's P/E ratio is -0.22. In terms of profitability, EMR's ROE is +0.12%, compared to NPWR's ROE of -1.45%. Regarding short-term risk, EMR is less volatile compared to NPWR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NPWR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, HURC has a market cap of 97.3M. Regarding current trading prices, EMR is priced at $132.24, while HURC trades at $14.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas HURC's P/E ratio is -6.28. In terms of profitability, EMR's ROE is +0.12%, compared to HURC's ROE of -0.07%. Regarding short-term risk, EMR is less volatile compared to HURC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HURC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, SHMDW has a market cap of 90.4M. Regarding current trading prices, EMR is priced at $132.24, while SHMDW trades at $2.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas SHMDW's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to SHMDW's ROE of -0.86%. Regarding short-term risk, EMR is less volatile compared to SHMDW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SHMDW's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, XCH has a market cap of 80.3M. Regarding current trading prices, EMR is priced at $132.24, while XCH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas XCH's P/E ratio is -2.70. In terms of profitability, EMR's ROE is +0.12%, compared to XCH's ROE of +45.25%. Regarding short-term risk, EMR is less volatile compared to XCH. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check XCH's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, PYR has a market cap of 68M. Regarding current trading prices, EMR is priced at $132.24, while PYR trades at $0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas PYR's P/E ratio is -3.17. In terms of profitability, EMR's ROE is +0.12%, compared to PYR's ROE of -1.12%. Regarding short-term risk, EMR is less volatile compared to PYR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PYR's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, BWEN has a market cap of 50.8M. Regarding current trading prices, EMR is priced at $132.24, while BWEN trades at $2.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas BWEN's P/E ratio is 9.52. In terms of profitability, EMR's ROE is +0.12%, compared to BWEN's ROE of +0.08%. Regarding short-term risk, EMR is less volatile compared to BWEN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BWEN's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, BURU has a market cap of 27.8M. Regarding current trading prices, EMR is priced at $132.24, while BURU trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas BURU's P/E ratio is 0.01. In terms of profitability, EMR's ROE is +0.12%, compared to BURU's ROE of +1.69%. Regarding short-term risk, EMR is less volatile compared to BURU. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BURU's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CVV has a market cap of 27.6M. Regarding current trading prices, EMR is priced at $132.24, while CVV trades at $3.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CVV's P/E ratio is -132.67. In terms of profitability, EMR's ROE is +0.12%, compared to CVV's ROE of -0.01%. Regarding short-term risk, EMR is less volatile compared to CVV. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CVV's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, GTEC has a market cap of 16.2M. Regarding current trading prices, EMR is priced at $132.24, while GTEC trades at $0.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas GTEC's P/E ratio is 0.75. In terms of profitability, EMR's ROE is +0.12%, compared to GTEC's ROE of +0.21%. Regarding short-term risk, EMR is less volatile compared to GTEC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GTEC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, LASE has a market cap of 16.1M. Regarding current trading prices, EMR is priced at $132.24, while LASE trades at $1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas LASE's P/E ratio is -2.35. In terms of profitability, EMR's ROE is +0.12%, compared to LASE's ROE of -1.18%. Regarding short-term risk, EMR is less volatile compared to LASE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check LASE's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, WFF has a market cap of 11.2M. Regarding current trading prices, EMR is priced at $132.24, while WFF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas WFF's P/E ratio is -22.22. In terms of profitability, EMR's ROE is +0.12%, compared to WFF's ROE of +0.04%. Regarding short-term risk, EMR is less volatile compared to WFF. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check WFF's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CGRN has a market cap of 6.8M. Regarding current trading prices, EMR is priced at $132.24, while CGRN trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CGRN's P/E ratio is -0.42. In terms of profitability, EMR's ROE is +0.12%, compared to CGRN's ROE of -0.30%. Regarding short-term risk, EMR is less volatile compared to CGRN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CGRN's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, TPIC has a market cap of 6.2M. Regarding current trading prices, EMR is priced at $132.24, while TPIC trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas TPIC's P/E ratio is -0.03. In terms of profitability, EMR's ROE is +0.12%, compared to TPIC's ROE of +0.76%. Regarding short-term risk, EMR is less volatile compared to TPIC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check TPIC's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, HCAI has a market cap of 5.8M. Regarding current trading prices, EMR is priced at $132.24, while HCAI trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas HCAI's P/E ratio is 3.60. In terms of profitability, EMR's ROE is +0.12%, compared to HCAI's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to HCAI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HCAI's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, JCSE has a market cap of 5.5M. Regarding current trading prices, EMR is priced at $132.24, while JCSE trades at $1.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas JCSE's P/E ratio is -4.73. In terms of profitability, EMR's ROE is +0.12%, compared to JCSE's ROE of -0.08%. Regarding short-term risk, EMR is less volatile compared to JCSE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check JCSE's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, INLF has a market cap of 4.4M. Regarding current trading prices, EMR is priced at $132.24, while INLF trades at $0.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas INLF's P/E ratio is -6.46. In terms of profitability, EMR's ROE is +0.12%, compared to INLF's ROE of -0.06%. Regarding short-term risk, EMR is less volatile compared to INLF. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check INLF's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CETY has a market cap of 4.4M. Regarding current trading prices, EMR is priced at $132.24, while CETY trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CETY's P/E ratio is -0.72. In terms of profitability, EMR's ROE is +0.12%, compared to CETY's ROE of -0.85%. Regarding short-term risk, EMR is less volatile compared to CETY. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CETY's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, LBGJ has a market cap of 1.9M. Regarding current trading prices, EMR is priced at $132.24, while LBGJ trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas LBGJ's P/E ratio is -1.68. In terms of profitability, EMR's ROE is +0.12%, compared to LBGJ's ROE of -0.13%. Regarding short-term risk, EMR is less volatile compared to LBGJ. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check LBGJ's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, NMHIW has a market cap of 76K. Regarding current trading prices, EMR is priced at $132.24, while NMHIW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas NMHIW's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to NMHIW's ROE of +0.93%. Regarding short-term risk, EMR is less volatile compared to NMHIW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NMHIW's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, NMHI has a market cap of 45.1K. Regarding current trading prices, EMR is priced at $132.24, while NMHI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas NMHI's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to NMHI's ROE of +0.93%. Regarding short-term risk, EMR is less volatile compared to NMHI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NMHI's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, BGRYW has a market cap of 0. Regarding current trading prices, EMR is priced at $132.24, while BGRYW trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas BGRYW's P/E ratio is -0.01. In terms of profitability, EMR's ROE is +0.12%, compared to BGRYW's ROE of -0.96%. Regarding short-term risk, EMR is more volatile compared to BGRYW. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check BGRYW's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, WBT has a market cap of 0. Regarding current trading prices, EMR is priced at $132.24, while WBT trades at $24.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas WBT's P/E ratio is 47.08. In terms of profitability, EMR's ROE is +0.12%, compared to WBT's ROE of +0.22%. Regarding short-term risk, EMR is more volatile compared to WBT. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check WBT's competition here

EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR stands at 74.4B. In comparison, CFXA has a market cap of 0. Regarding current trading prices, EMR is priced at $132.24, while CFXA trades at $177.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR currently has a P/E ratio of 32.42, whereas CFXA's P/E ratio is 248.89. In terms of profitability, EMR's ROE is +0.12%, compared to CFXA's ROE of -0.56%. Regarding short-term risk, EMR is less volatile compared to CFXA. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CFXA's competition here